Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.14 trillion and total revenue of $105.3 billion.
Market Cap
1.14T
Revenue
105.3B
Profits
-41.5B
PE Ratio
n/a
Profit Margin
-39.41%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.84B | 0.23% | 1,330,101 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.31B | -0.26% | 676,418 | 14.25B |
| 3 | ARGX | argenx SE | 50.44B | -1.48% | 370,666 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.29B | -3.25% | 1,634,592 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.55B | 0.15% | 167,589 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.32B | -2.61% | 2,506,109 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.10B | -2.10% | 1,066,258 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.32B | 0.72% | 3,533,950 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.74B | -0.99% | 2,522,362 | - |
| 10 | GMAB | Genmab A/S | 20.67B | 2.36% | 1,865,687 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.02B | -2.92% | 2,360,758 | 4.81B |
| 12 | MRNA | Moderna, Inc. | 19.03B | -6.09% | 19,929,517 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.70B | -1.70% | 6,018,707 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.01B | -2.55% | 2,582,932 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 14.45B | 2.95% | 1,255,656 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.00B | -1.84% | 2,153,114 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.72B | -5.07% | 3,083,449 | - |
| 18 | EXEL | Exelixis, Inc. | 11.92B | -0.52% | 2,117,458 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.94B | -0.19% | 1,117,791 | 20.87M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.91B | -3.53% | 434,832 | 740.64M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.80B | -1.70% | 2,106,366 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.62B | -2.14% | 1,900,380 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.25B | -1.34% | 1,085,246 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.76B | -1.22% | 747,575 | 6.23M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.37B | -0.55% | 426,610 | 561.26M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.21B | -3.65% | 1,930,398 | 829.45M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.65B | 2.41% | 553,572 | 7.46M |
| 28 | NUVL | Nuvalent, Inc. | 8.27B | -4.96% | 448,557 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 8.16B | -2.63% | 331,214 | 373.16M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.14B | -2.90% | 1,782,002 | 1.24B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.75B | -2.34% | 1,494,175 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.05B | -2.15% | 1,691,370 | 649.06M |
| 33 | PCVX | Vaxcyte, Inc. | 6.90B | -2.04% | 1,991,677 | - |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.87B | -5.07% | 476,375 | 174.33M |
| 35 | IBRX | ImmunityBio, Inc. | 6.35B | -12.13% | 75,850,201 | 82.56M |
| 36 | GPCR | Structure Therapeutics Inc. | 6.25B | -1.63% | 942,059 | - |
| 37 | BLTE | Belite Bio, Inc | 6.17B | 2.96% | 112,266 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.04B | -1.21% | 882,213 | 1.78B |
| 39 | KYMR | Kymera Therapeutics, Inc. | 5.59B | -3.90% | 635,113 | 43.74M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.58B | -7.21% | 3,068,024 | - |
| 41 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.45B | -3.22% | 1,222,343 | 1.54M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.29B | -8.70% | 2,393,068 | 38.34M |
| 43 | IMVT | Immunovant, Inc. | 5.27B | -0.65% | 1,131,774 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.20B | -1.99% | 569,251 | 209.22M |
| 45 | CELC | Celcuity Inc. | 5.09B | -0.65% | 978,274 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.87B | -1.81% | 802,708 | 471.79M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.73B | -12.32% | 4,241,291 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 4.63B | 6.49% | 3,946,512 | 741.17M |
| 49 | TGTX | TG Therapeutics, Inc. | 4.56B | -1.36% | 1,857,123 | 531.90M |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 4.54B | -2.44% | 1,951,216 | 1.05B |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.52B | -7.27% | 908,591 | - |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.41B | - | 8,627,704 | 598.70M |
| 53 | CGON | CG Oncology, Inc. | 4.34B | -3.65% | 1,814,325 | 2.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 3.98B | -3.85% | 2,412,666 | 488.56M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 3.96B | -1.31% | 198,809 | 251.23M |
| 56 | ACLX | Arcellx, Inc. | 3.91B | -1.34% | 828,598 | 35.90M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.78B | -4.28% | 547,034 | 35.24M |
| 58 | TERN | Terns Pharmaceuticals, Inc. | 3.73B | -4.56% | 2,171,166 | - |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.69B | 2.52% | 1,887,845 | 15.00M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.64B | -5.49% | 2,835,483 | - |
| 61 | LQDA | Liquidia Corporation | 3.53B | -1.17% | 1,960,209 | 69.22M |
| 62 | LEGN | Legend Biotech Corporation | 3.51B | -1.71% | 3,059,936 | 909.05M |
| 63 | VERA | Vera Therapeutics, Inc. | 3.37B | -2.51% | 661,184 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.23B | -1.14% | 522,089 | 7.50M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | -1.69% | 1,111,951 | 317.93M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.16B | -3.25% | 2,103,370 | - |
| 67 | VRDN | Viridian Therapeutics, Inc. | 3.14B | 2.36% | 1,959,750 | 70.79M |
| 68 | BEAM | Beam Therapeutics Inc. | 3.11B | -7.88% | 2,122,380 | 55.70M |
| 69 | ALMS | Alumis Inc. | 3.06B | -6.70% | 2,404,988 | 22.12M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -3.87% | 973,169 | 214.83M |
| 71 | ERAS | Erasca, Inc. | 3.05B | -3.21% | 6,771,509 | - |
| 72 | EWTX | Edgewise Therapeutics, Inc. | 3.03B | -3.93% | 1,123,347 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.96B | -0.44% | 2,748,701 | - |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 2.90B | -3.76% | 388,918 | 366.10M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | -3.56% | 1,069,930 | 578.20M |
| 76 | IRON | Disc Medicine, Inc. | 2.88B | -2.39% | 592,099 | - |
| 77 | IMNM | Immunome, Inc. | 2.85B | 0.19% | 2,080,075 | 9.68M |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.83B | -2.68% | 1,342,830 | 252.75M |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.75B | -1.14% | 2,215,555 | 1.02B |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.74B | -4.03% | 764,954 | 240.00M |
| 81 | TVTX | Travere Therapeutics, Inc. | 2.63B | -0.98% | 1,767,791 | 435.83M |
| 82 | MLYS | Mineralys Therapeutics, Inc. | 2.59B | -4.38% | 1,211,043 | - |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.55B | -0.13% | 118,124 | 664.23M |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.49B | -6.03% | 407,680 | - |
| 85 | WVE | Wave Life Sciences Ltd. | 2.46B | -2.53% | 2,244,446 | 109.23M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.46B | -4.64% | 18,327,608 | 43.69M |
| 87 | AAPG | Ascentage Pharma Group International | 2.40B | 1.07% | 1,937 | 54.52M |
| 88 | MESO | Mesoblast Limited | 2.38B | -2.08% | 107,935 | 17.20M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 3.46% | 3,695,693 | 630.60M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.28B | -3.18% | 1,290,220 | 98.68M |
| 91 | GLPG | Galapagos NV | 2.27B | - | 105,849 | 336.64M |
| 92 | DNTH | Dianthus Therapeutics, Inc. | 2.24B | -0.82% | 989,864 | 3.08M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -3.03% | 4,973,365 | 2.41B |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.19B | -7.64% | 4,878,479 | 55.78M |
| 95 | MAZE | Maze Therapeutics, Inc. | 2.13B | -4.18% | 548,272 | 2.50M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | 0.16% | 340,621 | 825.94M |
| 97 | CRVS | Corvus Pharmaceuticals, Inc. | 2.07B | -1.65% | 5,453,808 | - |
| 98 | ZLAB | Zai Lab Limited | 2.04B | -0.22% | 271,761 | 441.63M |
| 99 | OLMA | Olema Pharmaceuticals, Inc. | 1.98B | -4.50% | 766,529 | - |
| 100 | NUVB | Nuvation Bio Inc. | 1.92B | -5.41% | 6,021,334 | 26.75M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | -2.22% | 966,995 | 265.81M |
| 102 | VCEL | Vericel Corporation | 1.91B | -3.30% | 478,268 | 258.72M |
| 103 | SION | Sionna Therapeutics, Inc. | 1.89B | 1.46% | 199,343 | - |
| 104 | ARDX | Ardelyx, Inc. | 1.89B | -2.02% | 4,237,791 | 398.23M |
| 105 | NRIX | Nurix Therapeutics, Inc. | 1.88B | -4.28% | 977,485 | 83.69M |
| 106 | PHVS | Pharvaris N.V. | 1.82B | - | 185,890 | - |
| 107 | GLUE | Monte Rosa Therapeutics, Inc. | 1.81B | -0.78% | 1,185,445 | 181.54M |
| 108 | BHVN | Biohaven Ltd. | 1.79B | -1.82% | 1,848,347 | - |
| 109 | IMCR | Immunocore Holdings plc | 1.77B | 0.23% | 630,575 | 379.59M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -2.60% | 1,084,393 | 111.30M |
| 111 | ZYME | Zymeworks Inc. | 1.74B | -1.32% | 732,322 | 134.48M |
| 112 | CLDX | Celldex Therapeutics, Inc. | 1.72B | -3.46% | 361,236 | 2.60M |
| 113 | DFTX | Definium Therapeutics, Inc. | 1.71B | 2.53% | 2,765,168 | - |
| 114 | MBX | MBX Biosciences, Inc. | 1.70B | -10.71% | 860,449 | - |
| 115 | NTLA | Intellia Therapeutics, Inc. | 1.69B | -7.99% | 8,085,063 | 57.53M |
| 116 | PGEN | Precigen, Inc. | 1.68B | -1.65% | 4,851,027 | 6.31M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.68B | -1.96% | 503,741 | 205.63M |
| 118 | MNKD | MannKind Corporation | 1.68B | -7.61% | 4,518,395 | 313.79M |
| 119 | RAPT | RAPT Therapeutics, Inc. | 1.67B | -0.02% | 1,931,013 | - |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.66B | -3.21% | 451,697 | - |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | -0.42% | 833,533 | 44.79M |
| 122 | UPB | Upstream Bio, Inc. | 1.62B | -5.57% | 371,092 | 2.80M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.62B | -1.75% | 580,595 | - |
| 124 | KOD | Kodiak Sciences Inc. | 1.60B | -7.77% | 526,491 | - |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.58B | -5.18% | 1,569,550 | 66.50M |
| 126 | OCS | Oculis Holding AG | 1.57B | 1.61% | 287,698 | 992.00K |
| 127 | QURE | uniQure N.V. | 1.56B | 10.53% | 4,246,824 | 15.75M |
| 128 | FTRE | Fortrea Holdings Inc. | 1.56B | -3.00% | 679,099 | 2.76B |
| 129 | ELVN | Enliven Therapeutics, Inc. | 1.53B | -4.62% | 706,150 | - |
| 130 | ATAI | AtaiBeckley Inc. | 1.51B | 4.53% | 5,058,325 | 3.02M |
| 131 | NVAX | Novavax, Inc. | 1.49B | -5.95% | 7,589,646 | 1.06B |
| 132 | DBVT | DBV Technologies S.A. | 1.48B | 6.18% | 1,097,951 | 5.50M |
| 133 | INVA | Innoviva, Inc. | 1.46B | -0.91% | 478,845 | 388.52M |
| 134 | SVRA | Savara Inc. | 1.45B | -6.81% | 1,166,273 | - |
| 135 | PHAR | Pharming Group N.V. | 1.35B | -1.15% | 16,712 | 362.27M |
| 136 | IVA | Inventiva S.A. | 1.34B | 1.27% | 680,593 | 19.93M |
| 137 | IMTX | Immatics N.V. | 1.33B | -2.36% | 281,040 | 99.45M |
| 138 | ANAB | AnaptysBio, Inc. | 1.32B | 0.44% | 253,421 | 169.47M |
| 139 | RLAY | Relay Therapeutics, Inc. | 1.29B | -2.24% | 2,016,938 | 8.36M |
| 140 | SANA | Sana Biotechnology, Inc. | 1.29B | -3.40% | 2,128,873 | - |
| 141 | RAPP | Rapport Therapeutics, Inc. | 1.28B | -3.55% | 225,790 | - |
| 142 | TRVI | Trevi Therapeutics, Inc. | 1.28B | -8.68% | 1,277,969 | - |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | -8.45% | 4,457,355 | 6.31M |
| 144 | ABCL | AbCellera Biologics Inc. | 1.27B | -8.62% | 5,802,917 | 35.33M |
| 145 | EYPT | EyePoint, Inc. | 1.26B | -7.10% | 1,096,039 | 42.34M |
| 146 | XERS | Xeris Biopharma Holdings, Inc. | 1.23B | -2.23% | 1,669,112 | 266.14M |
| 147 | DAWN | Day One Biopharmaceuticals, Inc. | 1.23B | -3.16% | 3,182,432 | 133.67M |
| 148 | CAPR | Capricor Therapeutics, Inc. | 1.20B | -4.01% | 1,253,234 | 11.13M |
| 149 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -0.50% | 1,779,287 | - |
| 150 | SEPN | Septerna, Inc. | 1.15B | -3.26% | 177,845 | 22.05M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.14B | -3.35% | 232,911 | 5.56M |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.13B | 1.54% | 1,349,048 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.09B | -6.08% | 122,025 | 1.40M |
| 154 | ZBIO | Zenas BioPharma, Inc. | 1.08B | -1.52% | 453,831 | 15.00M |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | -4.86% | 1,475,950 | 147.19M |
| 156 | VIR | Vir Biotechnology, Inc. | 1.05B | 2.16% | 3,480,294 | 16.86M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.05B | -5.90% | 2,342,065 | 850.00K |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 1.05B | -1.86% | 12,112,427 | 250.43M |
| 159 | GHRS | GH Research PLC | 1.04B | -0.06% | 292,038 | - |
| 160 | TBPH | Theravance Biopharma, Inc. | 1.03B | -2.41% | 552,197 | 80.33M |
| 161 | NBTX | Nanobiotix S.A. | 1.01B | -2.06% | 8,658 | 11.93M |
| 162 | ANNX | Annexon, Inc. | 1.01B | -2.59% | 2,337,070 | - |
| 163 | PVLA | Palvella Therapeutics, Inc. | 1.01B | -7.36% | 258,493 | - |
| 164 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | 12.18% | 419,293 | - |
| 165 | SPRY | ARS Pharmaceuticals, Inc. | 1.01B | -3.41% | 1,450,939 | 142.77M |
| 166 | VTYX | Ventyx Biosciences, Inc. | 1.01B | 0.79% | 4,870,555 | - |
| 167 | AVBP | ArriVent BioPharma, Inc. | 958.35M | -7.88% | 410,864 | - |
| 168 | MRVI | Maravai LifeSciences Holdings, Inc. | 948.67M | -3.13% | 666,464 | 192.44M |
| 169 | CTMX | CytomX Therapeutics, Inc. | 938.67M | -3.15% | 3,025,450 | 113.63M |
| 170 | URGN | UroGen Pharma Ltd. | 936.18M | - | 1,003,235 | 96.52M |
| 171 | BCAX | Bicara Therapeutics Inc. | 917.05M | -4.83% | 334,290 | - |
| 172 | XNCR | Xencor, Inc. | 912.63M | -2.52% | 616,797 | 150.13M |
| 173 | JANX | Janux Therapeutics, Inc. | 890.79M | -2.18% | 1,632,283 | 10.00M |
| 174 | GERN | Geron Corporation | 880.93M | -2.13% | 11,938,423 | 183.40M |
| 175 | YDES | YD Bio Limited | 869.15M | 0.49% | 11,752 | 510.36K |
| 176 | DRUG | Bright Minds Biosciences Inc. | 851.32M | -3.75% | 79,993 | - |
| 177 | OMER | Omeros Corporation | 845.84M | -1.81% | 1,175,442 | - |
| 178 | VALN | Valneva SE | 837.21M | -5.10% | 9,472 | 211.09M |
| 179 | ARVN | Arvinas, Inc. | 827.85M | 2.55% | 815,884 | 312.30M |
| 180 | ENGN | enGene Holdings Inc. | 815.20M | 14.38% | 1,831,202 | - |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 809.75M | -3.14% | 487,485 | 1.43M |
| 182 | PRME | Prime Medicine, Inc. | 784.28M | -5.24% | 2,254,568 | 5.98M |
| 183 | MPLT | MapLight Therapeutics, Inc. | 782.93M | -3.44% | 126,234 | - |
| 184 | ABUS | Arbutus Biopharma Corporation | 780.84M | -2.40% | 1,143,005 | 14.61M |
| 185 | MDXG | MiMedx Group, Inc. | 779.02M | -2.95% | 1,164,767 | 393.44M |
| 186 | NKTR | Nektar Therapeutics | 754.88M | 1.59% | 1,012,393 | 62.60M |
| 187 | KURA | Kura Oncology, Inc. | 750.96M | -5.06% | 1,672,406 | 104.03M |
| 188 | JBIO | Jade Biosciences, Inc. | 750.10M | -4.20% | 307,292 | - |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 738.45M | -0.56% | 729,255 | - |
| 190 | SLS | SELLAS Life Sciences Group, Inc. | 725.40M | -5.54% | 3,988,381 | - |
| 191 | ATXS | Astria Therapeutics, Inc. | 718.13M | - | - | 706.00K |
| 192 | GYRE | Gyre Therapeutics, Inc. | 710.76M | -2.86% | 65,539 | 107.27M |
| 193 | FULC | Fulcrum Therapeutics, Inc. | 709.18M | -2.71% | 665,168 | 80.00M |
| 194 | RGNX | REGENXBIO Inc. | 698.09M | -13.70% | 1,411,508 | 161.32M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 670.87M | -2.56% | 358,886 | 282.08M |
| 196 | PROK | ProKidney Corp. | 652.81M | -0.46% | 601,274 | 744.00K |
| 197 | MGTX | MeiraGTx Holdings plc | 651.98M | -2.53% | 368,478 | 27.42M |
| 198 | VOR | Vor Biopharma Inc. | 642.37M | -3.94% | 742,058 | - |
| 199 | LENZ | LENZ Therapeutics, Inc. | 639.57M | -3.90% | 904,836 | 17.50M |
| 200 | GOSS | Gossamer Bio, Inc. | 624.93M | -5.92% | 4,250,709 | 44.05M |
| 201 | LXRX | Lexicon Pharmaceuticals, Inc. | 617.78M | -3.41% | 3,460,569 | 70.86M |
| 202 | LBRX | LB Pharmaceuticals Inc | 604.90M | 1.40% | 125,893 | - |
| 203 | REPL | Replimune Group, Inc. | 604.80M | -2.41% | 1,018,459 | - |
| 204 | ALT | Altimmune, Inc. | 600.35M | 2.23% | 15,507,157 | 20.00K |
| 205 | TENX | Tenax Therapeutics, Inc. | 596.38M | -0.54% | 196,453 | - |
| 206 | DRTS | Alpha Tau Medical Ltd. | 596.00M | -2.51% | 409,080 | - |
| 207 | IVVD | Invivyd, Inc. | 594.99M | -4.52% | 3,027,415 | 50.04M |
| 208 | EVMN | Evommune, Inc. | 594.86M | -0.11% | 235,339 | 13.00M |
| 209 | NBY | NovaBay Pharmaceuticals, Inc. | 594.28M | -14.05% | 1,055,675 | 10.30M |
| 210 | KROS | Keros Therapeutics, Inc. | 584.64M | -1.39% | 315,649 | 246.72M |
| 211 | DSGN | Design Therapeutics, Inc. | 579.89M | -4.14% | 179,618 | - |
| 212 | CRMD | CorMedix Inc. | 572.80M | -2.28% | 2,515,169 | 214.30M |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 569.50M | -6.36% | 784,596 | 180.61M |
| 214 | FBRX | Forte Biosciences, Inc. | 566.51M | -0.72% | 412,564 | - |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 557.58M | -7.14% | 546,058 | - |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 547.40M | -2.34% | 695,835 | - |
| 217 | OCGN | Ocugen, Inc. | 544.29M | 0.61% | 4,653,832 | 5.37M |
| 218 | PRTA | Prothena Corporation plc | 538.30M | -3.29% | 659,527 | 11.79M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 536.62M | -2.24% | 49,997 | 41.00K |
| 220 | ANRO | Alto Neuroscience, Inc. | 516.01M | -3.32% | 135,882 | - |
| 221 | SLDB | Solid Biosciences Inc. | 514.21M | -3.79% | 856,529 | - |
| 222 | ZVRA | Zevra Therapeutics, Inc. | 504.99M | -1.21% | 1,448,960 | 84.39M |
| 223 | MNPR | Monopar Therapeutics Inc. | 501.36M | 4.22% | 349,610 | - |
| 224 | VSTM | Verastem, Inc. | 492.42M | -4.63% | 1,974,895 | 13.38M |
| 225 | ACRS | Aclaris Therapeutics, Inc. | 487.55M | -0.66% | 2,558,922 | 15.74M |
| 226 | BCYC | Bicycle Therapeutics plc | 482.11M | -3.74% | 151,798 | 28.34M |
| 227 | NAGE | Niagen Bioscience, Inc. | 481.34M | -4.30% | 648,121 | 124.71M |
| 228 | CTNM | Contineum Therapeutics, Inc. | 474.52M | 2.85% | 202,857 | - |
| 229 | VNDA | Vanda Pharmaceuticals Inc. | 473.36M | -1.11% | 484,371 | 212.07M |
| 230 | AVXL | Anavex Life Sciences Corp. | 469.97M | -0.75% | 1,229,744 | - |
| 231 | IMMP | Immutep Limited | 465.73M | 7.82% | 346,197 | 3.31M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 455.95M | 2.16% | 267,616 | - |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.47M | -0.11% | 71,934 | - |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 454.80M | -1.61% | 539,720 | 120.00K |
| 235 | NBP | NovaBridge Biosciences | 448.48M | - | 460,584 | - |
| 236 | ADCT | ADC Therapeutics SA | 447.20M | -5.00% | 758,386 | 75.21M |
| 237 | ASMB | Assembly Biosciences, Inc. | 443.04M | 1.41% | 73,271 | 37.19M |
| 238 | PRTC | PureTech Health plc | 441.58M | -2.80% | 995 | 6.39M |
| 239 | ABSI | Absci Corporation | 437.58M | -7.91% | 3,636,424 | 2.82M |
| 240 | VTVT | vTv Therapeutics Inc. | 424.76M | 2.06% | 19,029 | 17.00K |
| 241 | BNTC | Benitec Biopharma Inc. | 422.94M | -2.65% | 82,547 | - |
| 242 | ZURA | Zura Bio Limited | 413.55M | -1.40% | 529,174 | - |
| 243 | TRDA | Entrada Therapeutics, Inc. | 409.90M | -2.39% | 374,726 | 61.52M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 402.59M | -1.59% | 2,412,271 | - |
| 245 | LCTX | Lineage Cell Therapeutics, Inc. | 390.15M | -2.42% | 698,396 | 10.82M |
| 246 | AUTL | Autolus Therapeutics plc | 388.57M | -3.95% | 1,879,161 | 51.13M |
| 247 | ALLO | Allogene Therapeutics, Inc. | 386.54M | - | 7,538,591 | 22.00K |
| 248 | TECX | Tectonic Therapeutic, Inc. | 377.32M | 5.83% | 279,619 | - |
| 249 | HELP | Cybin Inc. | 376.27M | -2.20% | 266,540 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 375.79M | 1.72% | 280,565 | 65.32M |
| 251 | PEPG | PepGen Inc. | 374.68M | -3.20% | 586,993 | - |
| 252 | ACIU | AC Immune SA | 366.09M | 1.93% | 573,743 | 5.48M |
| 253 | AURA | Aura Biosciences, Inc. | 360.70M | -1.05% | 162,083 | - |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 352.88M | 8.11% | 598,861 | - |
| 255 | NMRA | Neumora Therapeutics, Inc. | 350.07M | -1.90% | 783,384 | - |
| 256 | IMRX | Immuneering Corporation | 346.10M | 0.37% | 1,916,142 | - |
| 257 | FHTX | Foghorn Therapeutics Inc. | 344.46M | -5.16% | 110,525 | 24.52M |
| 258 | CADL | Candel Therapeutics, Inc. | 340.37M | -1.59% | 749,953 | - |
| 259 | TARA | Protara Therapeutics, Inc. | 331.71M | 4.74% | 931,333 | - |
| 260 | XOMA | XOMA Royalty Corporation | 330.63M | -0.82% | 623,489 | 47.11M |
| 261 | AARD | Aardvark Therapeutics, Inc. | 326.82M | -0.46% | 117,958 | - |
| 262 | RZLT | Rezolute, Inc. | 326.40M | 7.65% | 4,874,724 | - |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 323.52M | -1.60% | 221,981 | 33.98M |
| 264 | PBYI | Puma Biotechnology, Inc. | 323.51M | -6.41% | 555,447 | 212.00M |
| 265 | AVIR | Atea Pharmaceuticals, Inc. | 321.88M | 12.88% | 1,902,998 | - |
| 266 | GUTS | Fractyl Health, Inc. | 320.55M | 0.97% | 4,548,006 | 3.00K |
| 267 | CLLS | Cellectis S.A. | 317.62M | 1.14% | 11,950 | 82.55M |
| 268 | LRMR | Larimar Therapeutics, Inc. | 315.83M | 6.96% | 3,036,548 | - |
| 269 | ALDX | Aldeyra Therapeutics, Inc. | 312.24M | -0.57% | 1,256,130 | - |
| 270 | CABA | Cabaletta Bio, Inc. | 306.12M | 8.16% | 10,867,043 | - |
| 271 | ACHV | Achieve Life Sciences, Inc. | 298.11M | 1.45% | 468,100 | - |
| 272 | AVTX | Avalo Therapeutics, Inc. | 291.58M | -3.08% | 249,538 | 192.00K |
| 273 | RLMD | Relmada Therapeutics, Inc. | 286.00M | -1.52% | 909,492 | - |
| 274 | PALI | Palisade Bio, Inc. | 284.60M | 3.24% | 3,933,578 | - |
| 275 | NGNE | Neurogene Inc. | 283.62M | -3.79% | 78,496 | 925.00K |
| 276 | IMMX | Immix Biopharma, Inc. | 283.50M | 2.48% | 820,340 | - |
| 277 | OABI | OmniAb, Inc. | 282.15M | -5.31% | 337,044 | 21.09M |
| 278 | ABEO | Abeona Therapeutics Inc. | 279.63M | -3.73% | 1,398,155 | 400.00K |
| 279 | SLN | Silence Therapeutics plc | 267.82M | -2.58% | 261,701 | 25.83M |
| 280 | STTK | Shattuck Labs, Inc. | 262.61M | -4.82% | 5,587,479 | 1.00M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 261.62M | -1.79% | 56,605 | 38.79M |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 261.45M | -8.81% | 227,511 | - |
| 283 | HRTX | Heron Therapeutics, Inc. | 260.37M | -2.07% | 1,085,571 | 155.10M |
| 284 | ENLV | Enlivex Therapeutics Ltd. | 256.37M | 2.86% | 534,762 | - |
| 285 | CBIO | Crescent Biopharma, Inc. | 250.24M | -6.09% | 144,078 | - |
| 286 | CHRS | Coherus Oncology, Inc. | 248.99M | 29.56% | 21,606,170 | 277.73M |
| 287 | CLYM | Climb Bio, Inc. | 239.68M | 2.24% | 619,316 | - |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 238.00M | -3.33% | 346,795 | 1.00 |
| 289 | MENS | Jyong Biotech Ltd. | 233.01M | -4.11% | 306,891 | - |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 228.12M | -2.18% | 123,604 | 2.82M |
| 291 | TNXP | Tonix Pharmaceuticals Holding Corp. | 227.01M | -3.63% | 444,573 | 10.30M |
| 292 | MDWD | MediWound Ltd. | 226.94M | 1.14% | 114,974 | 20.93M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 222.40M | -2.44% | 514,421 | 31.32M |
| 294 | OVID | Ovid Therapeutics Inc. | 220.01M | -3.43% | 1,589,440 | 6.61M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 219.26M | -2.28% | 44,555 | - |
| 296 | ARMP | Armata Pharmaceuticals, Inc. | 218.44M | -3.07% | 28,296 | 5.05M |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 213.96M | -0.79% | 423,282 | 97.60M |
| 298 | GALT | Galectin Therapeutics Inc. | 213.40M | -6.23% | 283,892 | - |
| 299 | ALEC | Alector, Inc. | 211.75M | 1.04% | 671,870 | 69.05M |
| 300 | IPSC | Century Therapeutics, Inc. | 211.30M | 4.76% | 2,217,369 | 113.34M |
| 301 | EDIT | Editas Medicine, Inc. | 210.86M | -9.24% | 2,248,518 | 46.38M |
| 302 | CCCC | C4 Therapeutics, Inc. | 208.37M | -1.38% | 770,143 | 30.11M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 208.04M | -14.13% | 143,094 | 3.80M |
| 304 | TLSA | Tiziana Life Sciences Ltd | 204.12M | -1.81% | 215,253 | - |
| 305 | HUMA | Humacyte, Inc. | 202.65M | -6.25% | 4,970,036 | 1.57M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 201.13M | -0.50% | 2,167,979 | - |
| 307 | SGMT | Sagimet Biosciences Inc. | 199.68M | -3.31% | 755,563 | - |
| 308 | RNAC | Cartesian Therapeutics, Inc. | 197.63M | 0.26% | 88,509 | 1.09M |
| 309 | CGEN | Compugen Ltd. | 195.49M | -2.34% | 154,296 | 6.90M |
| 310 | CRDF | Cardiff Oncology, Inc. | 195.35M | -2.36% | 408,895 | 501.00K |
| 311 | SABS | SAB Biotherapeutics, Inc. | 192.33M | 1.00% | 488,988 | 114.70K |
| 312 | ZNTL | Zentalis Pharmaceuticals, Inc. | 190.37M | -9.54% | 916,075 | 26.87M |
| 313 | PRQR | ProQR Therapeutics N.V. | 184.35M | 2.34% | 508,598 | 18.86M |
| 314 | KLRS | Kalaris Therapeutics, Inc. | 183.28M | 0.20% | 37,032 | - |
| 315 | NKTX | Nkarta, Inc. | 176.86M | 3.75% | 1,788,716 | - |
| 316 | IRD | Opus Genetics, Inc. | 176.55M | 2.40% | 388,583 | 14.63M |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 172.93M | 1.49% | 24,709 | 59.99K |
| 318 | NERV | Minerva Neurosciences, Inc. | 171.80M | 1.79% | 71,325 | - |
| 319 | QNCX | Quince Therapeutics, Inc. | 171.50M | -4.94% | 1,153,222 | - |
| 320 | ELDN | Eledon Pharmaceuticals, Inc. | 169.81M | -4.04% | 690,127 | - |
| 321 | IPHA | Innate Pharma S.A. | 169.00M | 0.56% | 5,118 | 14.84M |
| 322 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | - | 649,213 | 1.20M |
| 323 | SRZN | Surrozen, Inc. | 167.96M | -2.03% | 48,774 | 3.60M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 167.28M | -0.48% | 417,972 | 61.84M |
| 325 | PRLD | Prelude Therapeutics Incorporated | 166.44M | -8.60% | 213,976 | 10.50M |
| 326 | CNTX | Context Therapeutics Inc. | 166.30M | 1.12% | 2,032,854 | - |
| 327 | SLGL | Sol-Gel Technologies Ltd. | 162.80M | 1.63% | 25,494 | 18.97M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 161.75M | -1.47% | 100,206 | - |
| 329 | VXRT | Vaxart, Inc. | 160.76M | 1.48% | - | 148.20M |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 158.11M | -3.13% | 2,439,245 | - |
| 331 | CDXS | Codexis, Inc. | 151.74M | -8.20% | 1,222,228 | 52.93M |
| 332 | MOLN | Molecular Partners AG | 149.91M | 2.01% | 6,424 | 856.30K |
| 333 | UNCY | Unicycive Therapeutics, Inc. | 148.72M | -2.95% | 483,934 | - |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 148.70M | -1.51% | 793,298 | 70.00M |
| 335 | TTRX | Turn Therapeutics Inc. | 143.10M | 2.75% | 53,824 | - |
| 336 | CRBU | Caribou Biosciences, Inc. | 143.01M | -5.56% | 957,275 | 9.30M |
| 337 | CNTB | Connect Biopharma Holdings Limited | 141.99M | -4.51% | 99,039 | 762.00K |
| 338 | ELTX | Elicio Therapeutics, Inc. | 141.55M | 1.12% | 98,516 | - |
| 339 | FATE | Fate Therapeutics, Inc. | 139.58M | -3.20% | 1,360,406 | 7.14M |
| 340 | SPRO | Spero Therapeutics, Inc. | 137.47M | -0.41% | 151,705 | 40.55M |
| 341 | MCRB | Seres Therapeutics, Inc. | 136.15M | -2.27% | 38,825 | 351.00K |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 134.93M | 2.11% | 217,780 | 2.00M |
| 343 | ONCY | Oncolytics Biotech Inc. | 133.43M | -2.36% | 1,711,817 | - |
| 344 | ACOG | Alpha Cognition Inc. | 129.37M | 4.39% | 22,830 | 7.43M |
| 345 | STRO | Sutro Biopharma, Inc. | 128.22M | -7.78% | 70,923 | 105.65M |
| 346 | SGMO | Sangamo Therapeutics, Inc. | 127.67M | -4.79% | 3,939,510 | 32.88M |
| 347 | WHWK | Whitehawk Therapeutics, Inc. | 127.25M | -5.26% | 70,344 | 14.38M |
| 348 | GNLX | Genelux Corporation | 127.10M | -0.35% | 193,385 | 8.00K |
| 349 | CGTX | Cognition Therapeutics, Inc. | 126.23M | -2.05% | 1,326,495 | - |
| 350 | ACTU | Actuate Therapeutics, Inc. | 123.89M | -2.20% | 79,098 | - |
| 351 | KPTI | Karyopharm Therapeutics Inc. | 120.66M | -0.75% | 323,396 | 142.53M |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 119.94M | -0.50% | 141,706 | - |
| 353 | VRCA | Verrica Pharmaceuticals Inc. | 118.64M | -4.01% | 72,107 | 30.83M |
| 354 | ADAG | Adagene Inc. | 117.36M | 22.66% | 1,994,170 | 103.20K |
| 355 | ARTV | Artiva Biotherapeutics, Inc. | 117.32M | -3.43% | 174,824 | 251.00K |
| 356 | THAR | Tharimmune, Inc. | 117.01M | -1.66% | 360,922 | - |
| 357 | MGNX | MacroGenics, Inc. | 113.87M | 2.27% | 1,110,054 | 127.63M |
| 358 | RPTX | Repare Therapeutics Inc. | 112.94M | 1.16% | 290,050 | 11.87M |
| 359 | AGEN | Agenus Inc. | 110.19M | -4.14% | 476,277 | 106.83M |
| 360 | ANIX | Anixa Biosciences, Inc. | 108.81M | -1.21% | 153,793 | - |
| 361 | VANI | Vivani Medical, Inc. | 107.97M | 0.68% | 191,240 | - |
| 362 | SEER | Seer, Inc. | 107.44M | -2.05% | 104,105 | 16.38M |
| 363 | SAVA | Cassava Sciences, Inc. | 106.28M | -5.17% | 690,438 | - |
| 364 | HYFT | MindWalk Holdings Corp. | 105.99M | -1.30% | 463,049 | 19.02M |
| 365 | FBIO | Fortress Biotech, Inc. | 105.53M | -2.30% | 472,124 | 62.30M |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 103.74M | -3.21% | 860,683 | 182.34K |
| 367 | PYXS | Pyxis Oncology, Inc. | 101.49M | -4.68% | 376,619 | 2.82M |
| 368 | DTIL | Precision BioSciences, Inc. | 101.10M | -1.18% | 216,748 | 698.00K |
| 369 | KRRO | Korro Bio, Inc. | 101.05M | 2.09% | 254,767 | 7.37M |
| 370 | ETHZ | ETHZilla Corporation | 99.62M | -0.57% | 210,017 | 4.11M |
| 371 | EXOZ | eXoZymes, Inc. | 99.56M | 2.17% | 1,568 | -700.00 |
| 372 | COYA | Coya Therapeutics, Inc. | 98.76M | -0.21% | 304,840 | 3.99M |
| 373 | MAIA | MAIA Biotechnology, Inc. | 97.96M | 6.67% | 1,558,407 | - |
| 374 | ANL | Adlai Nortye Ltd. | 97.05M | 28.92% | 171,030 | -1.35M |
| 375 | DWTX | Dogwood Therapeutics, Inc. | 95.61M | -2.93% | 44,061 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 94.74M | -6.29% | 1,141,062 | - |
| 377 | CSBR | Champions Oncology, Inc. | 93.73M | -2.60% | 3,362 | 58.42M |
| 378 | MNOV | MediciNova, Inc. | 91.41M | 12.05% | 272,504 | 257.92K |
| 379 | CBUS | Cibus, Inc. | 88.93M | 3.14% | 528,029 | 3.79M |
| 380 | SPRB | Spruce Biosciences, Inc. | 87.26M | -4.36% | 21,530 | 697.00K |
| 381 | ACET | Adicet Bio, Inc. | 85.30M | 0.48% | 110,765 | - |
| 382 | MREO | Mereo BioPharma Group plc | 83.88M | -0.96% | 5,905,042 | 500.00K |
| 383 | OKYO | OKYO Pharma Limited | 83.50M | -6.33% | 1,102,810 | - |
| 384 | ATOS | Atossa Therapeutics, Inc. | 82.94M | -1.91% | 752,069 | - |
| 385 | IMUX | Immunic, Inc. | 82.67M | -0.16% | 1,380,373 | - |
| 386 | KZIA | Kazia Therapeutics Limited | 81.83M | 7.29% | 338,557 | 1.20M |
| 387 | XBIT | XBiotech Inc. | 81.71M | 0.75% | 17,700 | - |
| 388 | PLRX | Pliant Therapeutics, Inc. | 79.88M | - | 1,251,720 | - |
| 389 | ANVS | Annovis Bio, Inc. | 79.77M | -1.63% | 313,604 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 79.52M | -3.58% | 52,679 | 501.00K |
| 391 | PYPD | PolyPid Ltd. | 79.51M | -0.62% | 42,080 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 78.85M | -1.44% | 615,602 | - |
| 393 | IMA | ImageneBio, Inc. | 77.54M | 2.97% | 49,200 | 800.00K |
| 394 | EQ | Equillium, Inc. | 77.33M | 7.63% | 599,790 | 4.39M |
| 395 | PTHS | Pelthos Therapeutics Inc. | 76.40M | 1.64% | 7,336 | 7.41M |
| 396 | ALXO | ALX Oncology Holdings Inc. | 75.91M | -4.76% | 85,552 | - |
| 397 | CALC | CalciMedica, Inc. | 75.79M | 0.24% | 32,138 | - |
| 398 | ENTX | Entera Bio Ltd. | 73.37M | 1.27% | 176,566 | 124.00K |
| 399 | ATYR | aTyr Pharma, Inc. | 70.85M | -3.12% | 740,222 | 190.00K |
| 400 | TVGN | Tevogen Bio Holdings Inc. | 70.48M | -4.29% | 213,338 | - |
| 401 | IFRX | InflaRx N.V. | 68.42M | -1.94% | 908,732 | 73.73K |
| 402 | BYSI | BeyondSpring Inc. | 66.62M | -2.99% | 14,434 | 1.88M |
| 403 | TCRX | TScan Therapeutics, Inc. | 64.69M | -3.39% | 416,632 | 8.42M |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 64.69M | 0.99% | 856,971 | - |
| 405 | NRXP | NRx Pharmaceuticals, Inc. | 64.24M | -7.26% | 688,907 | 242.00K |
| 406 | MGX | Metagenomi Therapeutics, Inc. | 63.45M | -3.43% | 195,352 | 30.91M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 62.26M | 2.63% | 394,516 | - |
| 408 | LPCN | Lipocine Inc. | 60.57M | 4.45% | 133,262 | 4.32M |
| 409 | ATHE | Alterity Therapeutics Limited | 59.47M | 8.56% | 25,517 | 3.57M |
| 410 | GRCE | Grace Therapeutics, Inc. | 59.11M | 0.53% | 92,567 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 58.68M | 1.13% | 14,022 | - |
| 412 | NTRB | Nutriband Inc. | 58.35M | 6.19% | 30,269 | 2.28M |
| 413 | CRVO | CervoMed Inc. | 58.11M | -4.56% | 96,055 | 6.16M |
| 414 | ICCC | ImmuCell Corporation | 56.63M | -4.57% | 26,966 | 27.77M |
| 415 | LONA | LeonaBio, Inc. | 55.80M | -5.21% | 28,763 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 55.72M | -2.38% | 13,753 | 8.20M |
| 417 | PDSB | PDS Biotechnology Corporation | 51.98M | -1.97% | 442,190 | - |
| 418 | NRXS | NeurAxis, Inc. | 51.77M | 4.97% | 51,476 | 3.36M |
| 419 | OSTX | OS Therapies Incorporated | 51.77M | - | 301,436 | - |
| 420 | IBIO | iBio, Inc. | 50.60M | -5.86% | 726,910 | 500.00K |
| 421 | ALGS | Aligos Therapeutics, Inc. | 49.97M | -4.92% | 158,828 | 2.65M |
| 422 | IBO | Impact BioMedical Inc. | 49.36M | -1.49% | 18,854 | 25.00K |
| 423 | CVM | CEL-SCI Corporation | 49.02M | -9.05% | 64,617 | - |
| 424 | ABVC | ABVC BioPharma, Inc. | 48.56M | -0.96% | 44,035 | 797.92K |
| 425 | TIL | Instil Bio, Inc. | 48.42M | 1.13% | 76,842 | - |
| 426 | QTTB | Q32 Bio Inc. | 48.36M | -4.15% | 166,016 | - |
| 427 | PSTV | Plus Therapeutics, Inc. | 47.96M | -4.88% | 21,053,023 | 5.26M |
| 428 | LITS | Lite Strategy, Inc. | 46.70M | -3.79% | 344,931 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | - | 71,238 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.26M | 0.49% | 23,253 | - |
| 431 | INMB | INmune Bio Inc. | 45.19M | - | 259,730 | 50.00K |
| 432 | VERU | Veru Inc. | 44.94M | 4.09% | 145,247 | 16.89M |
| 433 | TVRD | Tvardi Therapeutics, Inc. | 44.00M | -2.90% | 29,369 | - |
| 434 | ANEB | Anebulo Pharmaceuticals, Inc. | 43.96M | -2.73% | 19,449 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.93M | - | 345,460 | - |
| 436 | XLO | Xilio Therapeutics, Inc. | 42.47M | 1.85% | 718,369 | 31.80M |
| 437 | ESLA | Estrella Immunopharma, Inc. | 42.45M | 7.03% | 92,432 | - |
| 438 | NXTC | NextCure, Inc. | 41.72M | -5.93% | 23,379 | - |
| 439 | GLTO | Galecto, Inc. | 41.15M | -12.91% | 46,400 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 40.55M | -2.99% | 180,355 | 90.00K |
| 441 | HURA | TuHURA Biosciences, Inc. | 40.54M | -1.71% | 210,398 | - |
| 442 | PASG | Passage Bio, Inc. | 39.99M | -0.94% | 84,715 | - |
| 443 | OKUR | OnKure Therapeutics, Inc. | 39.70M | -3.93% | 81,554 | - |
| 444 | XCUR | Exicure, Inc. | 39.26M | -4.20% | 40,115 | 500.00K |
| 445 | LTRN | Lantern Pharma Inc. | 38.70M | -1.98% | 22,553 | - |
| 446 | APLM | Apollomics, Inc. | 38.63M | -3.69% | 13,072 | 6.93M |
| 447 | GBIO | Generation Bio Co. | 38.37M | -0.09% | 64,365 | 15.27M |
| 448 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 38.09M | -3.15% | 2,424,437 | - |
| 449 | ATRA | Atara Biotherapeutics, Inc. | 37.64M | 4.40% | 363,667 | 151.93M |
| 450 | CELU | Celularity Inc. | 37.20M | 1.18% | 23,633 | 40.58M |
| 451 | RNXT | RenovoRx, Inc. | 36.50M | -2.37% | 112,093 | 928.00K |
| 452 | LSTA | Lisata Therapeutics, Inc. | 36.25M | 1.23% | 191,492 | 1.07M |
| 453 | RNTX | Rein Therapeutics Inc. | 36.01M | 2.24% | 124,160 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 35.36M | -2.56% | 10,699 | 8.30M |
| 455 | CING | Cingulate Inc. | 35.06M | -9.12% | 562,056 | - |
| 456 | MRKR | Marker Therapeutics, Inc. | 35.01M | 2.94% | 221,947 | 4.69M |
| 457 | CUE | Cue Biopharma, Inc. | 34.67M | 4.17% | 994,481 | 7.10M |
| 458 | EVAX | Evaxion A/S | 33.69M | -3.58% | 104,295 | 7.65M |
| 459 | PLUR | Pluri Inc. | 33.13M | 0.91% | 7,659 | 1.33M |
| 460 | HOWL | Werewolf Therapeutics, Inc. | 32.75M | -3.17% | 250,689 | 1.14M |
| 461 | DYAI | Dyadic International, Inc. | 32.57M | -1.32% | 21,830 | 3.34M |
| 462 | SKYE | Skye Bioscience, Inc. | 32.38M | -3.81% | 194,929 | - |
| 463 | OTLK | Outlook Therapeutics, Inc. | 32.25M | -1.37% | 2,133,855 | 1.41M |
| 464 | ANTX | AN2 Therapeutics, Inc. | 32.06M | -3.31% | 66,111 | - |
| 465 | GNTA | Genenta Science S.p.A. | 31.16M | -0.75% | 49,261 | - |
| 466 | JUNS | Jupiter Neurosciences, Inc. | 30.64M | -4.81% | 47,220 | - |
| 467 | SER | Serina Therapeutics, Inc. | 30.61M | -3.04% | 23,539 | 116.00K |
| 468 | BRNS | Barinthus Biotherapeutics plc | 29.44M | -0.96% | 11,738 | 14.97M |
| 469 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.01M | -0.60% | 61,084 | - |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 28.48M | 2.01% | 182,544 | - |
| 471 | PTN | Palatin Technologies, Inc. | 28.43M | -0.60% | 17,069 | 8.85M |
| 472 | SNTI | Senti Biosciences, Inc. | 28.39M | -6.90% | 288,805 | - |
| 473 | RLYB | Rallybio Corporation | 28.37M | -0.16% | 106,909 | 674.00K |
| 474 | BOLD | Boundless Bio, Inc. | 28.27M | -0.55% | 61,224 | - |
| 475 | IGC | IGC Pharma, Inc. | 27.88M | -3.35% | 254,259 | 1.11M |
| 476 | DARE | Daré Bioscience, Inc. | 27.86M | -1.02% | 78,705 | -57.13K |
| 477 | FBLG | FibroBiologics, Inc. | 26.61M | 17.65% | 1,805,933 | - |
| 478 | IOBT | IO Biotech, Inc. | 26.41M | -23.56% | 17,365,231 | - |
| 479 | HYPD | Hyperion DeFi, Inc. | 25.53M | 4.11% | 301,162 | 345.32K |
| 480 | VTGN | Vistagen Therapeutics, Inc. | 25.49M | -2.60% | 773,048 | 721.00K |
| 481 | PLRZ | Polyrizon Ltd. | 25.41M | 1.72% | 98,648 | - |
| 482 | NNVC | NanoViricides, Inc. | 24.80M | - | 265,258 | - |
| 483 | CLGN | CollPlant Biotechnologies Ltd. | 24.28M | 24.18% | 147,439 | 2.48M |
| 484 | KLTO | Klotho Neurosciences, Inc. | 24.00M | -4.31% | 470,336 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 23.80M | -2.00% | 1,281,269 | - |
| 486 | INAB | IN8bio, Inc. | 23.44M | -3.23% | 53,745 | - |
| 487 | QNTM | Quantum BioPharma Ltd. | 23.34M | -1.90% | 46,042 | - |
| 488 | NEUP | Neuphoria Therapeutics Inc. | 22.75M | 1.44% | 37,133 | 15.65M |
| 489 | BCAB | BioAtla, Inc. | 22.42M | 10.31% | 8,106,096 | 11.00M |
| 490 | LEXX | Lexaria Bioscience Corp. | 21.15M | 4.03% | 158,987 | 522.00K |
| 491 | LIMN | Liminatus Pharma, Inc. | 20.92M | 0.40% | 31,328 | - |
| 492 | ALLR | Allarity Therapeutics, Inc. | 20.84M | -3.23% | 100,942 | - |
| 493 | KTTA | Pasithea Therapeutics Corp. | 20.78M | -0.96% | 90,248 | - |
| 494 | OSRH | OSR Holdings, Inc. | 20.75M | 5.52% | 1,212,665 | -90.52K |
| 495 | LNAI | Lunai Bioworks Inc. | 20.57M | -4.36% | 66,103 | - |
| 496 | PMN | ProMIS Neurosciences, Inc. | 20.30M | 1.95% | 23,737 | - |
| 497 | CASI | CASI Pharmaceuticals, Inc. | 19.73M | -2.79% | 64,013 | 26.85M |
| 498 | TRAW | Traws Pharma, Inc. | 19.34M | -2.81% | 85,302 | 2.85M |
| 499 | VYNE | VYNE Therapeutics Inc. | 19.32M | 0.09% | 192,403 | 524.00K |
| 500 | ITRM | Iterum Therapeutics plc | 19.18M | 3.68% | 731,852 | 390.00K |
| 501 | CTXR | Citius Pharmaceuticals, Inc. | 17.65M | 0.06% | 182,779 | - |
| 502 | KALA | KALA BIO, Inc. | 17.09M | 2.54% | 675,141 | - |
| 503 | CVKD | Cadrenal Therapeutics, Inc. | 16.97M | -4.97% | 17,607 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.45M | 0.95% | 388,034 | - |
| 505 | CLRB | Cellectar Biosciences, Inc. | 16.07M | -0.52% | 26,453 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.99M | -1.04% | 4,636,476 | 1.00M |
| 507 | KAPA | Kairos Pharma, Ltd. | 15.87M | -2.29% | 57,673 | - |
| 508 | TPST | Tempest Therapeutics, Inc. | 14.68M | -2.93% | 94,910 | - |
| 509 | MBRX | Moleculin Biotech, Inc. | 14.41M | -1.89% | 95,670 | - |
| 510 | COCP | Cocrystal Pharma, Inc. | 14.34M | -1.89% | 14,370 | - |
| 511 | BCDA | BioCardia, Inc. | 14.22M | 2.29% | 41,770 | 3.00K |
| 512 | SNGX | Soligenix, Inc. | 13.92M | -2.82% | 127,834 | 2.34K |
| 513 | NCNA | NuCana plc | 13.57M | 1.24% | 37,854 | - |
| 514 | SNSE | Sensei Biotherapeutics, Inc. | 13.31M | -6.88% | 240,031 | - |
| 515 | AEON | AEON Biopharma, Inc. | 13.14M | -5.13% | 163,291 | - |
| 516 | BOLT | Bolt Biotherapeutics, Inc. | 12.84M | 7.04% | 17,516 | 5.20M |
| 517 | AKTX | Akari Therapeutics, Plc | 12.53M | 1.94% | 406,133 | - |
| 518 | BLRX | BioLineRx Ltd. | 12.48M | 4.62% | 52,356 | 12.74M |
| 519 | LGVN | Longeveron Inc. | 12.48M | 6.60% | 118,588 | 1.44M |
| 520 | IMNN | Imunon, Inc. | 12.34M | 3.12% | 15,177 | - |
| 521 | NCEL | NewcelX Ltd. | 12.17M | 0.38% | 50,044 | - |
| 522 | CRIS | Curis, Inc. | 12.15M | 4.45% | 262,966 | 11.65M |
| 523 | EDSA | Edesa Biotech, Inc. | 12.08M | -2.03% | 8,041 | - |
| 524 | PHIO | Phio Pharmaceuticals Corp. | 11.73M | 0.93% | 202,571 | - |
| 525 | GDTC | CytoMed Therapeutics Limited | 11.54M | 5.25% | 10,133 | 573.19K |
| 526 | GRDX | GridAI Technologies Corp. | 10.74M | -10.00% | 177,649 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.34M | -1.75% | 35,847 | - |
| 528 | BRTX | BioRestorative Therapies, Inc. | 10.12M | -1.30% | 20,299 | 383.40K |
| 529 | PULM | Pulmatrix, Inc. | 9.71M | -0.81% | 5,018 | 3.00K |
| 530 | PMCB | PharmaCyte Biotech, Inc. | 9.51M | 4.34% | 1,409,267 | - |
| 531 | ERNA | Ernexa Therapeutics Inc. | 9.42M | -3.23% | 26,039 | 1,000.00 |
| 532 | XTLB | XTL Biopharmaceuticals Ltd. | 9.35M | 0.95% | 130,799 | 968.00K |
| 533 | ICU | SeaStar Medical Holding Corporation | 9.30M | -0.39% | 107,474 | 881.00K |
| 534 | BIVI | BioVie Inc. | 9.20M | -2.40% | 87,637 | - |
| 535 | MTVA | MetaVia Inc. | 9.08M | 1.43% | 516,426 | - |
| 536 | RNAZ | TransCode Therapeutics, Inc. | 9.05M | 5.90% | 20,615 | - |
| 537 | APVO | Aptevo Therapeutics Inc. | 8.96M | 0.56% | 21,786 | - |
| 538 | EVGN | Evogene Ltd. | 8.87M | 2.91% | 22,102 | 8.02M |
| 539 | IMRN | Immuron Limited | 8.50M | -1.30% | 16,332 | 4.78M |
| 540 | ALZN | Alzamend Neuro, Inc. | 8.36M | -3.51% | 128,062 | - |
| 541 | BCTX | BriaCell Therapeutics Corp. | 8.23M | -1.36% | 192,249 | - |
| 542 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.05M | -0.62% | 31,001 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 7.85M | - | 2,785 | 198.82K |
| 544 | APM | Aptorum Group Limited | 7.83M | -2.26% | 65,496 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | -4.07% | 73,386 | 20.00K |
| 546 | MBIO | Mustang Bio, Inc. | 7.66M | -1.87% | 23,588 | - |
| 547 | GTBP | GT Biopharma, Inc. | 7.57M | -1.11% | 511,480 | - |
| 548 | CLDI | Calidi Biotherapeutics, Inc. | 7.46M | -1.92% | 40,551 | - |
| 549 | PCSA | Processa Pharmaceuticals, Inc. | 7.39M | 2.84% | 90,670 | - |
| 550 | CELZ | Creative Medical Technology Holdings, Inc. | 7.34M | -6.67% | 68,278 | 6.00K |
| 551 | PPBT | Purple Biotech Ltd | 7.11M | 1.47% | 84,012 | - |
| 552 | ABP | Abpro Holdings, Inc. | 7.08M | -10.26% | 39,999 | 183.00K |
| 553 | TOVX | Theriva Biologics, Inc. | 7.02M | -4.78% | 1,899,108 | - |
| 554 | SLXN | Silexion Therapeutics Corp | 6.78M | 0.93% | 21,169 | - |
| 555 | GNPX | Genprex, Inc. | 6.59M | -3.07% | 433,663 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 6.54M | 1.38% | 16,626 | 6.00K |
| 557 | BGMS | Bio Green Med Solution, Inc. | 6.47M | -5.04% | 34,747 | 81.00K |
| 558 | ACXP | Acurx Pharmaceuticals, Inc. | 6.46M | -1.08% | 61,216 | - |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.43M | 0.65% | 370,227 | - |
| 560 | PHGE | BiomX Inc. | 6.12M | 12.32% | 629,196 | - |
| 561 | INDP | Indaptus Therapeutics, Inc. | 6.08M | -4.34% | 21,806 | - |
| 562 | XBIO | Xenetic Biosciences, Inc. | 6.07M | -4.19% | 30,745 | 2.86M |
| 563 | CYCN | Cyclerion Therapeutics, Inc. | 5.86M | 11.59% | 1,006,564 | 2.86M |
| 564 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.84M | -9.92% | 2,648,503 | 1.36M |
| 565 | APRE | Aprea Therapeutics, Inc. | 5.80M | -1.41% | 44,746 | 488.24K |
| 566 | CANF | Can-Fite BioPharma Ltd. | 5.74M | 7.45% | 77,775 | 560.00K |
| 567 | GOVX | GeoVax Labs, Inc. | 5.41M | 9.38% | 270,546 | 3.35M |
| 568 | ASBP | Aspire Biopharma Holdings, Inc. | 5.06M | 4.14% | 604,124 | 1.94K |
| 569 | DCOY | Decoy Therapeutics Inc. | 4.98M | 3.93% | 320,635 | - |
| 570 | VIVS | VivoSim Labs, Inc. | 4.96M | -5.00% | 21,311 | 140.00K |
| 571 | SILO | Silo Pharma, Inc. | 4.95M | 0.65% | 140,384 | 72.10K |
| 572 | PBM | Psyence Biomedical Ltd. | 4.69M | -3.46% | 225,679 | - |
| 573 | MTNB | Matinas BioPharma Holdings, Inc. | 4.61M | 22.03% | 125,710 | - |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 4.47M | -4.44% | 35,758 | - |
| 575 | SPRC | SciSparc Ltd. | 4.39M | - | 92,778 | 1.31M |
| 576 | ENVB | Enveric Biosciences, Inc. | 4.33M | -0.70% | 12,261 | - |
| 577 | ELAB | PMGC Holdings Inc. | 4.16M | -3.31% | 141,282 | 285.95K |
| 578 | CMND | Clearmind Medicine Inc. | 4.11M | 1.48% | 28,873 | - |
| 579 | XRTX | XORTX Therapeutics Inc. | 3.90M | 2.77% | 11,181 | - |
| 580 | REVB | Revelation Biosciences, Inc. | 3.83M | -24.40% | 92,677,897 | - |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 3.75M | -3.36% | 23,221 | - |
| 582 | PPCB | Propanc Biopharma, Inc. | 3.74M | 5.26% | 265,796 | - |
| 583 | HCWB | HCW Biologics Inc. | 3.65M | -2.88% | 92,834 | 422.03K |
| 584 | LYRA | Lyra Therapeutics, Inc. | 3.64M | -6.82% | 88,501 | 600.00K |
| 585 | OGEN | Oragenics, Inc. | 3.58M | -7.47% | 641,391 | - |
| 586 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.54M | -2.02% | 79,152 | 15.78K |
| 587 | ARTL | Artelo Biosciences, Inc. | 3.49M | - | 28,398 | - |
| 588 | JAGX | Jaguar Health, Inc. | 3.47M | 4.78% | 1,298,205 | 11.79M |
| 589 | SCNI | Scinai Immunotherapeutics Ltd. | 3.47M | 21.89% | 335,305 | 1.15M |
| 590 | ENSC | Ensysce Biosciences, Inc. | 3.12M | -3.34% | 68,772 | 4.49M |
| 591 | BBLG | Bone Biologics Corporation | 3.11M | -1.70% | 12,254 | - |
| 592 | AZTR | Azitra, Inc. | 3.07M | 0.70% | 1,894,279 | 7.50K |
| 593 | GRI | GRI Bio, Inc. | 2.81M | 2.60% | 1,889,885 | - |
| 594 | DRMA | Dermata Therapeutics, Inc. | 2.55M | -9.96% | 250,015 | - |
| 595 | ONCO | Onconetix, Inc. | 2.46M | -3.07% | 71,952 | 1.22M |
| 596 | CDT | CDT Equity Inc. | 2.10M | -13.57% | 224,133 | - |
| 597 | ADTX | Aditxt, Inc. | 2.08M | - | 1,205,484 | 5.95K |
| 598 | MLEC | Moolec Science SA | 2.01M | 10.62% | 127,781 | 7.83M |
| 599 | VRAX | Virax Biolabs Group Limited | 1.95M | -3.31% | 126,270 | 2.99K |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.80M | -0.92% | 206,998 | 104.90K |